Le Lézard
Classified in: Health
Subject: SVY

Global Human Enhancement Market Analysis & Trends Report 2018: Market Opportunities and Recommendations


DUBLIN, June 18, 2018 /PRNewswire/ --

The "Global Human Enhancement Market Analysis & Trends - Industry Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The Global Human Enhancement Market is poised to grow strong during the forecast period 2017 to 2027.

Some of the prominent trends that the market is witnessing include rising inclination towards health and growth in smart sensors.

Report Highlights:

Key Topics Covered:

1 Market Outline
1.1 Research Methodology
1.2 Market Trends
1.3 Regulatory Factors
1.4 Product Analysis
1.5 End User Analysis
1.6 Strategic Benchmarking
1.7 Opportunity Analysis

2 Executive Summary

3 Market Overview
3.1 Current Trends
3.1.1 Rising Inclination Towards Health
3.1.2 Growth in Smart Sensors
3.1.3 Recent Technological Developments in Human Enhancement
3.1.4 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness

4 Human Enhancement Market, By Product
4.1 Wearable Enhancement
4.1.1 Wearable Enhancement Market Forecast to 2027 (US$ MN)
4.1.1.1 Wrist-wear
4.1.1.2 Body-wear
4.1.1.3 Eye-wear
4.1.1.4 Foot-wear
4.1.1.4 Other Wearable Enhancement
4.2 In-built Enhancement

5 Human Enhancement Market, By End-user
5.1 Healthcare
5.2 Defense
5.3 Medical
5.4 Industrial
5.5 Other End Users

6 Human Enhancement Market, By Geography

7 Key Player Activities
7.1 Mergers & Acquisitions
7.2 Partnerships, Joint Venture's, Collaborations and Agreements
7.3 Product Launch & Expansions
7.4 Other Activities

8 Leading Companies

For more information about this report visit https://www.researchandmarkets.com/research/qfg9rm/global_human?w=5

Media Contact:


Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 02:22
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024 First Quarter 2024 Total revenue increased 19 per cent, 20 per cent at constant exchange rates, (CER)1, to SEK 6,256 M (5,239)Haematology revenue...

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com. The earnings release can be found at...

at 02:00
In response to the increasing complexities of the aging journey and the rising trend of...

at 02:00
PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that it has entered into a target-exclusive research and...

at 02:00
Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood...



News published on and distributed by: